Furthermore, we found a significant elevation in GSN expression of 11 malignancies: adrenocortical carcinoma (ACC), CHOL, lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), glioblastoma multiforme (GBM), KIRC, acute myeloid leukemia (LAML), brain lower grade glioma (LGG), LIHC, pancreatic adenocarcinoma (PAAD), testicular germ cell tumors (TGCT), thymoma (THYM). This evidence concerns the gene GSN and glioblastoma.